Currently, biopharma is the fastest growing and emerging sector in pharma. Many big pharma giants are now shifting their presence to biopharma domain. Biopharmaceuticals are proving to be lifesaving drugs for various dreadful diseases. Biopharmaceuticals are drugs produced using recombinant DNA technology or extracted from living systems. The recombinant human insulin (trade name “Humulin”) was the first biopharmaceutical approved for human therapeutic uses and marketed in 1982. Biopharmaceuticals are now well established as a clinically and commercially important class of therapeutics.